Live MD Anderson Cancer Center updates

Live MD Anderson Cancer Center news coverage of developments with the latest updates. Stay on top of latest MD Anderson Cancer Center news stories and find out what just happened, what is going on with MD Anderson Cancer Center. The latest real-time news updates and headlines on MD Anderson Cancer Center
MD Anderson Research Highlights for May 18, 2022
UT Researchers Aim to Change Cancer Equation
Adolescent and young adult leukemia survivors have shorter life span compared to those who have never had cancer
Adolescent and young adult leukemia survivors face higher mortality rates than general population for decades after diagnosis
TJ Gan, M.D., to join MD Anderson as Division Head of Anesthesiology, Critical Care and Pain Medicine
Young and facing melanoma second time
Targeting interleukin-6 could help relieve immunotherapy side effects
Patients with past cancer history not linked to higher risk of Covid-related death or hospitalization
MD Anderson and Community Health Network announce partnership to create fully integrated cancer program
Johns Hopkins Medicine Researchers Awarded Nearly $8 Million from Break Through Cancer Foundation
Rice trains postdocs for nano-cancer future
Extracellular vesicles offer new insights into treating endocrine disorders
MD Anderson receives over $10 million from Break Through Cancer to support collaborative research with leading cancer centers
Dana-Farber Cancer Institute receives $11M to intercept and cure deadly cancers
Vitamin E can boost immunotherapy responses by reinvigorating dendritic cells
MD Anderson research highlights for April 13, 2022
Long-term quality of life in breast cancer patients after breast conservation vs mastectomy, reconstruction
New platform optimizes selection of combination cancer therapies
Ranna Parekh, M.D., joins MD Anderson as Chief Diversity, Equity and Inclusion Officer
AACR: Combination immunotherapy treatment effective before lung cancer surgery
Therapies targeting DNA damage response show promising antitumor activity
Natural killer cells complexed with bispecific antibody may provide new treatment option for patients with advanced lymphoma
NK cells combined with bispecific antibody showed strong response for patients with lymphoma
AACR 2022 Special Edition
New machine learning models can predict adverse outcomes after abdominal hernia surgery with high accuracy
Machine learning can predict adverse outcomes after abdominal hernia surgery
Lee Ellis honored by AACR for contributions to education and training in cancer research
Karen Lu honored by AACR for contributions to cancer research
MD Anderson applauds Houston City Council for amending smoking ordinance to include e-cigarettes
Black patients with cancer fare worse with Covid
Novel therapy could help people with asthma, COPD, cystic fibrosis and cancer-related lung disease
New screening tool IDs 95%of stage 1 pancreatic cancer
SGO 2022 Special Edition
Axi-cel proves effective as first-line treatment for high-risk lymphoma
Computational approach enables spatial mapping of single-cell data within tissues
NCCN pharmacy directors forum publishes recommendations for safely dispensing investigational medications for clinical trials
MD Anderson research highlights for March 9, 2022
Study defines stem cell groups that drive myelodysplastic syndromes, finds potential targeted therapy option
‘Drug factory’ implants eliminate ovarian, colorectal cancer in mice
Finding Drugs for Formerly Undruggable Cancer Targets
Artificial intelligence and machine learning show promise in cancer diagnosis and treatment
Texas Life Science Forum honors top life science innovation companies
CPRIT supports work on combo cancer therapy
MD Anderson receives over $31 million in CPRIT funding
MD Anderson renews partnership with Banner Health
Specific cancer driving protein plays important role in lung cancer development
Rice team’s mask strategy passes muster
MD Anderson honors World Cancer Day, reinforces commitment to cancer care, prevention, research and education